University of Texas Health Science Center at Houston-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Texas Health Science Center at Houston - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014154
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Texas Health Science Center at Houston (UTHealth), a subsidiary of University of Texas System is an educational institution that provides research, education and patient care services. The university operates with schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. It offers clinical research education course that is conducted by clinical trial research professionals and examines the entire clinical trial process. The university’s teaching hospitals include Memorial Hermann-Texas Medical Center, Children’s Memorial Hermann Hospital and Harris Health Lyndon B. Johnson General Hospital. UTHealth is headquartered in Houston, Texas, the US.

University of Texas Health Science Center at Houston – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 10
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 11
Licensing Agreements 12
CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 12
Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 13
Cellvation Enters into Licensing Agreement with University of Texas Health Science Center at Houston 14
University of Texas Health Science Center at Houston – Key Competitors 15
University of Texas Health Science Center at Houston – Key Employees 16
University of Texas Health Science Center at Houston – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Government and Public Interest 19
Sep 28, 2017: UTHealth’s Jim Zheng awarded $5.8 million CPRIT grant to mine cancer data for cures 19
Aug 24, 2017: Research reveals how estrogen regulates gene expression 20
May 08, 2017: UTHealth researchers identify genes in children linked to stress, bipolar disorder 21
Sep 01, 2016: Mobile Stroke Unit Project Receives $6.8 Million from PCORI to Expand Research in Houston and Beyond 22
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Key Facts 2
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Texas Health Science Center at Houston, Deals By Therapy Area, 2011 to YTD 2017 8
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 10
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 11
CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 12
Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 13
Cellvation Enters into Licensing Agreement with University of Texas Health Science Center at Houston 14
University of Texas Health Science Center at Houston, Key Competitors 15
University of Texas Health Science Center at Houston, Key Employees 16
University of Texas Health Science Center at Houston, Other Locations 17
University of Texas Health Science Center at Houston, Subsidiaries 17

★海外企業調査レポート[University of Texas Health Science Center at Houston-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dr. August Oetker Kg
    Dr. August Oetker Kg - Strategy, SWOT and Corporate Finance Report Summary Dr. August Oetker Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Santen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic areas such as retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis co …
  • Synchronoss Technologies, Inc. (SNCR):企業の財務・戦略的SWOT分析
    Synchronoss Technologies, Inc. (SNCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Venture Lighting International Inc:企業の戦略的SWOT分析
    Venture Lighting International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Saline Water Conversion Corp:企業の戦略的SWOT分析
    Saline Water Conversion Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • KF Aerospace:企業の戦略・SWOT・財務情報
    KF Aerospace - Strategy, SWOT and Corporate Finance Report Summary KF Aerospace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tokyo Electric Power Company Holdings Inc (9501):企業の財務・戦略的SWOT分析
    Tokyo Electric Power Company Holdings Inc (9501) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Oilinvest (Netherlands) BV:企業の戦略的SWOT分析
    Oilinvest (Netherlands) BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nigerian Breweries Plc:企業の戦略・SWOT・財務情報
    Nigerian Breweries Plc - Strategy, SWOT and Corporate Finance Report Summary Nigerian Breweries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Flexible Solutions International Inc (FSI):企業の財務・戦略的SWOT分析
    Flexible Solutions International Inc (FSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Takara Bio Inc (4974):製薬・医療:M&Aディール及び事業提携情報
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Xtant Medical Holdings Inc (XTNT):企業の財務・戦略的SWOT分析
    Summary Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowr …
  • Zenkyoren:企業の戦略・SWOT・財務分析
    Zenkyoren - Strategy, SWOT and Corporate Finance Report Summary Zenkyoren - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Reach Subsea ASA (REACH):石油・ガス:M&Aディール及び事業提携情報
    Summary Reach Subsea ASA (Reach) provides engineering consultancy services and advanced remotely-operated underwater vessels (ROV) to the oil industry. The company also offers inspection, maintenance and repair, survey, construction support and decommissioning services. Reach offers multi-support ve …
  • Malaysian Pacific Industries Berhad (MPI):企業の財務・戦略的SWOT分析
    Malaysian Pacific Industries Berhad (MPI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Top Kinisis Travel Public Ltd:企業の戦略・SWOT・財務情報
    Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Cummins Inc (CMI)-エネルギー分野:企業M&A・提携分析
    Summary Cummins Inc. (Cummins) is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment devices, turbochargers, air handling …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆